Use of anti-prolactin agents to treat proliferative conditions
US7115556B2 · kind B2 · utility
11Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2002 |
| Grant date | Oct 3, 2006 |
| Priority date | — |
| Expiry date | Feb 25, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to variant forms of human prolactin which act as antagonists at the prolactin receptor, and to the use of such variants in the treatment of human cancers and proliferative disorders, including both benign and malignant diseases of the breast and prostate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.